{"id":684737,"date":"2022-09-13T09:33:17","date_gmt":"2022-09-13T13:33:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/"},"modified":"2022-09-13T09:33:17","modified_gmt":"2022-09-13T13:33:17","slug":"22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/","title":{"rendered":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <em>Aligned with FDA and Biden Administration Important Initiative to Limit Nicotine Content in Cigarettes and Ban Menthol<\/em>\n        <\/li>\n<li style=\"text-align:justify\">\n          <em>VLN<sup>\u00ae<\/sup> Reduced Nicotine Content Cigarettes Are Designed Specifically to \u201c<\/em><br \/>\n          <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-tobacco-products-help-reduce-exposure-and-consumption-nicotine-smokers-who\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong><br \/>\n              <em>Help You Smoke Less<\/em><br \/>\n            <\/strong><br \/>\n          <\/a><br \/>\n          <em>\u201d and Reduce Exposure to Activities Known to Cause Cancer<\/em>\n        <\/li>\n<li style=\"text-align:justify\">\n          <em>Exceptional Pilot Results in Chicago Lead to Expanding VLN<sup>\u00ae<\/sup> Points of Sale in Chicago and State of Illinois<\/em><br \/>\n          \n        <\/li>\n<\/ul>\n<p>BUFFALO, N.Y., Sept.  13, 2022  (GLOBE NEWSWIRE) &#8212; 22nd Century Group, Inc. (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y4F5FFjU1RbbyWYlk3IsnRUyZcOj42FZPnT_UTpvJeyhUfTB-opwYHu-Iyo_25FZ8VZXYUIWqW-3gRbVJgJN4FZflefa6AlcKHGIopjehFW0VfWPKDUyMfDwoFfm_TNV\" rel=\"nofollow noopener\" target=\"_blank\">XXII<\/a>), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp\/cannabis, and hops advanced plant technologies, today announced that it is engaged to power President Biden\u2019s plan to reduce the death rate from cancer by at least 50% over the next 25 years. The Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TorsAeVLqpLQaUSMbuagEW7YfMniy8W-TXVkEvZV-33EVj0Qm2JV8WEYdTMuooBelh4hGcqCktFBIFoRn5pZZX7uf_LhJQ4SAqmmhtsFezw5EN1OruphTNHr_rqc6F_jacqMb1qDnuAl27J0rWBJxS9Is2UBmlLNDdsuvjwhsQM=\" rel=\"nofollow noopener\" target=\"_blank\">VLN<sup>\u00ae<\/sup> King and VLN<sup>\u00ae<\/sup> Menthol King 95% reduced nicotine content cigarettes<\/a> are the first and only combustible cigarette designed specifically to \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=okN18g_NaOPpW2fzgxcJ5-u_D__YioW9uk285HTENzFTDcfhAGwfZnmTIIiUP2pznfUIWZtT_fR_0U9ZKEwHW350CZMiUerQy_kkCQTS7dLB5Fv6qR00KdaZoYnDdHLMMAlxedMPaKh6tXvXk1L59-PZxgHtzSuYWwZUrAKz7FKU5OGhZ8rS-_aeu-7dpi3tW_52eDbOAJ7Q7VU1mNsJRpuFsCdSZS32UZWMtDkxJ_ROY56AbXucDTjT2FoKqaC6\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Help You Smoke Less<\/strong><\/a>\u201d, which the U.S. Food and Drug Administration (FDA) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VdGT7HzOcbBbe0gjqDGR05M_HGLPYUPS7JUTGeNiT2RHnDz2SCCo8G7IIIXXjWaQGiiJlX5imtAokKoeAevLwUIv-JkFasW_qlmSu3Z8xVrp-YLyJlbzO4p3kY9Jg7NOrPm86mjNr6ml3sZ5GnuiyhkIijakQhVFC9j1ZDYi443slh_Pabt1hBZOGQ77XhAjHo7dfbc-uSxA-3hBAxkpruiwoFjmiy51-6rgyrhXbueavHqwrqRNJGaRVqYawilM\" rel=\"nofollow noopener\" target=\"_blank\">requires<\/a> to be printed right on the packaging. 22nd Century is expanding VLN<sup>\u00ae<\/sup> points of sale in Chicago and the State of Illinois after seeing exceptional pilot results in Chicagoland. Distribution will begin in September through various channels via retail and distribution partnerships.<\/p>\n<p>Under Biden\u2019s initiative, the FDA has taken aggressive actions aimed at curtailing smoking, in particular the Agency\u2019s pursuit to limit the amount of nicotine and ban menthol-flavored cigarettes. Every year, nearly 500,000 Americans die from smoking-related diseases. Smoking is the leading cause of cancer deaths, with more than 160,000 people perishing every year from cancers directly attributed to tobacco. Although nicotine itself is not the direct cause of most smoking-related diseases, addiction to nicotine in tobacco is the proximate cause of smoking related diseases including cancer. Thus, the magnitude of public health harm that is caused by tobacco is inextricably linked to its addictive nature.<\/p>\n<p>\u201cIt is well understood that addiction to nicotine is the primary driver of smoking, leading to smoking related diseases such as cancer. Rather than just another nicotine replacement therapy, 22nd Century\u2019s VLN<sup>\u00ae<\/sup> cigarettes take a disruptive approach to help people smoke less by reducing the nicotine content to levels the FDA considers non-addictive. Numerous clinical studies sponsored by federal health agencies demonstrate that adult smokers can successfully smoke less and improve their health situation by using reduced nicotine cigarettes to first break the nicotine addiction cycle. By smoking less, adult smokers can reduce their exposure to activities known to cause cancer,\u201d said James A. Mish, chief executive officer of 22nd Century Group.<\/p>\n<p>FDA Commissioner Robert M. Califf explained at a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9xIkw77wFjzl5xP9s05SWVANxSUxQabDgZ76X95ZluLexYerovM9u2RbmfsR53XLRw3_J3U-ySsB7aoBlmHXZWTNoZDh4DuKEdsCTBY3zlPNgIlEhwZi7BHXsLBo3pZlnlU7PdjjMUFh1_O60Zs4y5HTK8NnulUxOArZpSrxdT15nX8f7cbou7ch9OqPR96cTVXi08xMKPO_SyIjyJ0w_A==\" rel=\"nofollow noopener\" target=\"_blank\">conference<\/a> last week that the Agency\u2019s proposal to reduce nicotine content in cigarettes is based on nicotine\u2019s extremely high addictive potential. He was quoted saying, \u201cI think it\u2019s every bit as strong as the opioid addiction.\u201d<\/p>\n<p align=\"justify\">\u201cCancer doesn\u2019t discriminate between red or blue, it doesn\u2019t care if you\u2019re a Republican or a Democrat,\u201d said President Biden during his Moonshot Speech Monday afternoon. \u201cBeating cancer is something we can do together and that\u2019s why I\u2019m here today.\u201d<\/p>\n<p>Biden\u2019s Cancer Moonshot Initiative will bring together departments and agencies, including the National Institutes of Health (NIH), and the FDA, to address cancer on multiple fronts. These are the same government agencies that have funded numerous independent scientific studies demonstrating the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ledorhh1ss-6XlOAwj6i5AJRD3nDE-7i8SOop738tdEIIxRV55a4HiCsIGARgt1vQGLIcEviY2ehiKxvgqzTxwhGeFI6ZGP-KlAFtyiDKnt2_syCDIfUrpcxWIQszN3GL7hQ3Q27-jEKcf8zv062THEnTUJvBKTVE_cJbY5lPtnz-z6hnWiXUUADlEfRGC7N0n_4sGR4881MwWGwjizHJSGDnbhtojIiyfxsmY9-JNB1-zDIEggHRJ1Zg9zLsubh\" rel=\"nofollow noopener\" target=\"_blank\">benefits<\/a> of using reduced nicotine content tobacco cigarettes. 22nd Century\u2019s VLN<sup>\u00ae<\/sup> King and VLN<sup>\u00ae<\/sup> Menthol King cigarettes were engineered to contain 95% less nicotine than conventional cigarettes and is the only combustible product that is in line with the FDA\u2019s proposed nicotine cap. VLN<sup>\u00ae<\/sup> cigarettes smoke, smell, and taste like conventional cigarettes and are the only cigarettes in the world not designed to create or sustain nicotine addiction purposefully designed to \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=okN18g_NaOPpW2fzgxcJ5zME9q3Gs9SM2CD7ioh53RB5EXqA4wY9xsYfREY15skulHLkUDpfOXhYnIPrHGpK4d2AzWb2m4n1x2cWNX6_x-FdTPyGurGKCdwV64GW-28SnTew_56QzwFtUYegwl-ZZ5eX51NscPdE98kUSgj1VbJyW_B6lH14SxGAKaFVFo7kKyoGfNKzZWNRPRfygshWmCZp9mJdxEbaO98-4_A5_9mt-nt-J7t8XhjAk3Q9KECR\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Help You Smoke Less<\/strong><\/a>\u201d<strong>.<\/strong><\/p>\n<p>FDA\u2019s reduced nicotine mandate has the potential to help more than 5 million people quit smoking within the first year of implementation, prevent more than 33 million people from not becoming regular smokers, and prevent more than 8 million fewer people dying from tobacco-related illnesses, including cancer. The Agency also asserts that a proposed menthol ban is expected to have enormous health benefits for the nearly 20 million current smokers of menthol cigarettes. 22nd Century expects VLN<sup>\u00ae<\/sup> Menthol King reduced nicotine cigarettes to be exempted from FDA\u2019s menthol ban under procedures detailed in <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CnvH20C5siLNjr-AkfeaiRh7S2OEXMQkffZwyYRqPWE7gVRczh_IG119c1pGF3kDPtI6nV-17sVpAhZp-AGNX2eBxd3Xci-pNC68hORUyPhyqLEnFr5yGX2BDMSpKxmaEH2gQrYul8sU9MkreVj8dIpczUwwbwqf4X75y1jQQeSG57UwfO87MKV1rL3BJvNaZLYBBOovjakzNaExVw74Wd_lzE99feqmxjVdhsTnlm8nES0dEhYrUs_mQ0sqZLvg8p1xa8DIzp6eCXnnawfxDA==\" rel=\"nofollow noopener\" target=\"_blank\">FDA\u2019s proposed rule<\/a> announced April 28, 2022.<\/p>\n<p>\n        <strong>About 22nd Century Group, Inc.<\/strong><br \/>\n        <br \/>22nd Century Group, Inc. (Nasdaq:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v_Hh1ZQ6zGzy79T6vuivAvVxj6j6qGOk7gTZhzryZWhqBbXlrTKVMjE7PLTvT9pNk45aaXziCp5dGgOmZRrlvb5sZUr46KY0OnlDlY9KbTs=\" rel=\"nofollow noopener\" target=\"_blank\"><u>XXII<\/u><\/a>) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CnvH20C5siLNjr-AkfeaiVYv1dQFfGX9i_8P9vPsQ1xre3Zq41JMo-2OtCkAokPaKZ39k6fhBbdaBLT_tvFPvHOBYsRyO7ufI_ZYGaNd4ErclVS8aegy7bWg2U6gaHbk9oM_0sFcYlrBHnHTHIIhKBr5FIffMy2UVkz0Ke1iLr7ZN4aClSE4F93gPdTL4ADonIk9-VxBgjmNjAekAynoGQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>FDA\u2019s Comprehensive Plan<\/u><\/a>\u00a0to address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp\/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.<\/p>\n<p align=\"justify\">Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I9L4KBjaq5tttlhr24bCsJjXEuc8K4AsG68ncYDuFzxkG0GP2HlhB89YIQFJihsoe60HV1IDhWk8x4cDjd5SkWJSjZ0KivfZj8UJhDd2mQs=\" rel=\"nofollow noopener\" target=\"_blank\"><u>xxiicentury.com<\/u><\/a>, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rRx19KnrLdq9ZH8YaJDHVyecsb-m0OS0faUeHq_7Wr3bPLzvsDEfrqp1RbvpC4K_6tmMClZQfOgO5Xv46Nxby4Fq-WxT89UXAmtVBynHRp4=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Twitter<\/u><\/a>, on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PNH_HIf9QoulsbpQPtU9zjYeYodwDtcGr4Qzuo1xw8JyMbfQasYcCMiMVhfQNDxUPeJtkgprtvtLbdBkk8X_bZ4KOjfrm2zJJ0XjorAbyQ5-D3tDBaPyO5olXFfbgqos\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, and on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Ai5zWQuWhfpVesWybagdtLzIHKiUa0iqlBOrPgKxyQsaIDwF_WMXnd3dIQ0Xha_UqEBG_srv_QylJ-5mPoA8xdruJny89yiLvFYrLUAazaJQj5zSWPdYKNsWlOFKYIE\" rel=\"nofollow noopener\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">Learn more about VLN<sup>\u00ae<\/sup>\u00a0at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Uah3mFHVOtNnGF-vTPJiGiTmjmqWD-xFKVBvcD5rRHSfhXeoCn0UYJXYPMDWb9AfQ7VuBHLKzklJNqHtIJyFvw==\" rel=\"nofollow noopener\" target=\"_blank\">tryvln.com<\/a>.<\/p>\n<p>\n        <strong>Cautionary Note Regarding Forward-Looking Statements<\/strong><br \/>\n        <br \/>Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201cconsider,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cexplore,\u201d \u201cforesee,\u201d \u201cgoal,\u201d \u201cguidance,\u201d \u201cintend,\u201d \u201clikely,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cpreliminary,\u201d \u201cprobable,\u201d \u201cproject,\u201d \u201cpromising,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould,\u201d and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in \u201cRisk Factors\u201d in the Company\u2019s Annual Report on Form 10-K filed on March 1, 2022, and in the Company\u2019s Quarterly Report filed on August 9, 2022. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.<\/p>\n<p>\n        <strong>Investor Relations &amp; Media Contact<\/strong><br \/>\n        <br \/>Mei Kuo<br \/>22nd Century Group, Inc.<br \/>Director, Communications &amp; Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TKyF-JFuT8Ui2OTnf5_YYh0NMthU584INukQUUQrZ5wcfKpnMAxh81YoFOuTojYwM_261oOgMpYgnkCPrZYwk5UjdjP4b_h5EZ4KXyu-gzg=\" rel=\"nofollow noopener\" target=\"_blank\">mkuo@xxiicentury.com<\/a><\/p>\n<p>Darrow Associates Investor Relations<br \/>Matt Kreps<br \/>T: 214-597-8200<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mG42o2DTc5pxxGGk7NtdVU-98xlaOK8J1NOmKMrKBDPTkyLUPjOQKzzr2Ys8QGumRh745aHJ04ojPsdYbkW2oUQUgzHoS4cN9gs6z4zeG0M=\" rel=\"nofollow noopener\" target=\"_blank\">mkreps@darrowir.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQ2YzYyYjgtNTAxYy00YjdhLTlkYzktZWUyMmMxZDQ2YTRhLTEyMDAxNTU=\/tiny\/22nd-Century-Group-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aligned with FDA and Biden Administration Important Initiative to Limit Nicotine Content in Cigarettes and Ban Menthol VLN\u00ae Reduced Nicotine Content Cigarettes Are Designed Specifically to \u201c Help You Smoke Less \u201d and Reduce Exposure to Activities Known to Cause Cancer Exceptional Pilot Results in Chicago Lead to Expanding VLN\u00ae Points of Sale in Chicago and State of Illinois BUFFALO, N.Y., Sept. 13, 2022 (GLOBE NEWSWIRE) &#8212; 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp\/cannabis, and hops advanced plant technologies, today announced that it is engaged to power President Biden\u2019s plan to reduce the death rate from cancer by at least 50% over the next 25 years. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-684737","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Aligned with FDA and Biden Administration Important Initiative to Limit Nicotine Content in Cigarettes and Ban Menthol VLN\u00ae Reduced Nicotine Content Cigarettes Are Designed Specifically to \u201c Help You Smoke Less \u201d and Reduce Exposure to Activities Known to Cause Cancer Exceptional Pilot Results in Chicago Lead to Expanding VLN\u00ae Points of Sale in Chicago and State of Illinois BUFFALO, N.Y., Sept. 13, 2022 (GLOBE NEWSWIRE) &#8212; 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp\/cannabis, and hops advanced plant technologies, today announced that it is engaged to power President Biden\u2019s plan to reduce the death rate from cancer by at least 50% over the next 25 years. The &hellip; Continue reading &quot;22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-13T13:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative\",\"datePublished\":\"2022-09-13T13:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/\"},\"wordCount\":1080,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/\",\"name\":\"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\",\"datePublished\":\"2022-09-13T13:33:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/","og_locale":"en_US","og_type":"article","og_title":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk","og_description":"Aligned with FDA and Biden Administration Important Initiative to Limit Nicotine Content in Cigarettes and Ban Menthol VLN\u00ae Reduced Nicotine Content Cigarettes Are Designed Specifically to \u201c Help You Smoke Less \u201d and Reduce Exposure to Activities Known to Cause Cancer Exceptional Pilot Results in Chicago Lead to Expanding VLN\u00ae Points of Sale in Chicago and State of Illinois BUFFALO, N.Y., Sept. 13, 2022 (GLOBE NEWSWIRE) &#8212; 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp\/cannabis, and hops advanced plant technologies, today announced that it is engaged to power President Biden\u2019s plan to reduce the death rate from cancer by at least 50% over the next 25 years. The &hellip; Continue reading \"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-13T13:33:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative","datePublished":"2022-09-13T13:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/"},"wordCount":1080,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/","name":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=","datePublished":"2022-09-13T13:33:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NTY0OSM1MTUwMDgzIzIxODg2MDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-groups-nasdaq-xxii-vln-cigarettes-with-reduced-nicotine-technology-ready-to-ignite-bidens-cancer-moonshot-initiative\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"22nd Century Group\u2019s (Nasdaq: XXII) VLN\u00ae Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden\u2019s Cancer Moonshot Initiative"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/684737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=684737"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/684737\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=684737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=684737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=684737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}